| [1] |
中华医学会感染病学分会, 肝脏炎症及其防治专家共识专家委员会. 肝脏炎症及其防治专家共识[J]. 中华肝脏病杂志,2014,22(2):94-103.
|
| [2] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组. 酒精性肝病诊疗指南(2010年修订版)[J/CD]. 中国肝脏病杂志(电子版),2010,2(4):49-53.
|
| [3] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J/CD]. 中国肝脏病杂志(电子版),2010,2(4):43-48.
|
| [4] |
Shiffman RN, Shekelle P, Overhage JM, et al. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization[J]. Ann Intern Med,2003,139(6):493-498.
|
| [5] |
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations[J]. BMJ,2008,336(7650):924-926.
|
| [6] |
Kuntz E. The "essential" phospholipids in hepatology -- 50 years of experimental and clinical experiences[J]. Z Gastroenterol,1991,29(Suppl 2):7-13.
|
| [7] |
Navder KP, Lieber CS. Dilinoleoylphosphatidylcholine is responsible for the beneficial effects of polyenylphosphatidylcholine on ethanol-induced mitochondrial injury in rats[J]. Biochem Biophys Res Commun,2002,291(4):1109-1112.
|
| [8] |
Gundermann KJ, Kuenker A, Kuntz E, et al. Activity of essential phospholipids (EPL) from soybean in liver diseases[J]. Pharmacol Rep,2011,63(3):643-659
|
| [9] |
王涛, 陈东风. 多烯磷脂酰胆碱通过过氧化物酶体增殖物激活受体α/肉碱棕榈酰基转移酶1A通路影响肝细胞脂肪变性[J]. 中华肝脏病杂志,2016,24(4):291-296.
|
| [10] |
Ling J, Chaba T, Zhu LF, et al. Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice[J]. Hepatology,2012,55(4):1094-1102.
|
| [11] |
Cao M, Li X, Zhang B, et al. The effect of polyene phosphatidyl choline intervention on nonalcoholic steatohepatitis and related mechanism[J]. Am J Transl Res,2016,8(5):2325-2330.
|
| [12] |
van der Veen JN, Kennelly JP, Wan S, et al. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease[J]. Biochim Biophys Acta, 2017,1859:1558-1572.
|
| [13] |
Cantafora A, Masella R, Angelico M, et al. Effect of intravenous polyunsaturated phosphatidylcholine infusion on insulin receptor processing and lipid composition of erythrocytes in patients with liver cirrhosis[J]. Eur J Clin Invest,1992,22(12):777-782.
|
| [14] |
Navder KP, Baraona E, Lieber CS. Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats[J]. J Nutr,1997,127(9):1800-1806.
|
| [15] |
Saba P, Galeone F, Salvadorini F, et al. Effects of soybean polyunsaturated phosphatidylcholine (Lipoetabil R) on hyperlipoproteinemia[J]. Cuur Therap Res,1978,24:299-306.
|
| [16] |
Horsch AK, Majolk I, Heuck CC, et al. Influence of polyenphosphatidylcholine (PPC) on serum lipids of patients with hyperlipoproteinemis[J]. VASA,1986,15(3):251-256.
|
| [17] |
陈兰. 多烯磷脂酰胆碱对兔动脉粥样硬化防治的实验研究[D]. 新疆医科大学,2012.
|
| [18] |
Gonciarz Z, Besser P, Lelek E, et al. Randomised placebo-controlled double blind trial on essential phospholipids in the treatment of fatty liver associated with diabetes[J]. Médecine et Chirurgie Digestives,1988,17:61-65.
|
| [19] |
Sas E, Grinevich V, Efimov O, et al. Beneficial influence of polyunsaturated phosphatidylcholine enhances functional liver condition and liver structure in patients with nonalcoholic steatohepatitis. Results of prolonged randomized blinded prospective clinical study[J]. J Hepatol,2013,58(6):S549.
|
| [20] |
郭秀丽, 梁丕霞, 徐有青. 甘草酸二铵与多烯磷脂酰胆碱治疗非酒精性脂肪性肝炎的疗效比较[J]. 中国新药杂志,2012,21(3):289-292.
|
| [21] |
吴莘, 袁方, 黄欣, 等. 多烯磷脂酰胆碱联合甘草酸二铵治疗非酒精性脂肪性肝病疗效观察[J]. 中华消化杂志,2015,35(6):411-412.
|
| [22] |
Fan XF, Deng YQ, Ye L, et al. Effect of Xuezhikang Capsule on serum tumor necrosis factor-alpha and interleukin-6 in patients with nonalcoholic fatty liver disease and hyperlipidemia[J]. Chin J Integr Med,2010,16(2):119-123.
|
| [23] |
苏红领, 朱玉侠, 高正军, 等. 双环醇与多烯磷脂酰胆碱治疗非酒精性脂肪肝的疗效比较[J]. 中华肝脏病杂志,2011,19(7):552-553.
|
| [24] |
Dajani AI, Abu Hammour AM, Zakaria MA, et al. Essential phospholipids as a supportive adjunct in the management of patients with NAFLD[J]. Arab J Gastroenterol,2015,16(3-4):99-104.
|
| [25] |
郑盛, 刘海, 尹静, 等. 水飞蓟素胶囊联合多烯磷脂酰胆碱治疗非酒精性脂肪性肝炎的疗效观察[J]. 实用肝脏病杂志,2010,13(6):431-432.
|
| [26] |
吴伟奋, 潘业. 易善复结合有氧运动治疗非酒精性脂肪肝293例[J]. 齐齐哈尔医学院学报,2008,29(18):2202-2204.
|
| [27] |
乔永刚, 赵立平, 张妮. 易善复联合二甲双胍治疗肥胖相关非酒精性脂肪肝临床观察[J]. 内蒙古中医药,2014,33(6):13.
|
| [28] |
施伎蝉, 蒋贤高, 何贵清, 等. 熊去氧胆酸联合多烯磷脂酰胆碱治疗非酒精性脂肪性肝病的疗效观察[J]. 中国医师进修杂志,2013,36(24):58-60.
|
| [29] |
吴春晓, 陈燕鸿, 周晓蕾, 等. 多烯磷脂酰胆碱联合调脂治疗非酒精性脂肪性肝病的临床观察[J/CD]. 中国肝脏病杂志(电子版),2012,4(2):17-20.
|
| [30] |
李康, 刘旭明. 多烯磷脂酰胆碱联合托尼奈酸治疗非酒精性脂肪性肝炎疗效观察[J]. 肝脏,2013,22(12):825-826.
|
| [31] |
纪奕锋, 洪万东, 朱启槐. 左卡尼汀联合多烯磷脂酰胆碱治疗非酒精性脂肪肝的效果[J]. 实用医学杂志,2008,24(24):4286-4287.
|
| [32] |
Lieber CS, Weiss DG, Groszmann R, et al. Veterans affairs cooperative study of polyenylphosphatidylcholine in alcoholic liver disease[J]. Alcohol Clin Exp Res,2003,27(11):1765-1772.
|
| [33] |
Sas E, Grinevich V, Kravchuk U, et al. Polyunsaturated phosphati-dylcholine reduces insulin resistance and hepatic fibrosis in patients with alcoholic liver disease: results of randomized blinded prospective clinical study[J]. J Hepatol,2011,54(11):S207.
|
| [34] |
Schuller Perez A, Gonzales San Martin F. Placebo-controlled study with polyunsaturated phosphatidylcholine in alcoholic steatosis of the liver[J]. Med Welt,1985,36(17):517-521.
|
| [35] |
金玉坤, 罗雁, 陆伟. 易善复治疗酒精性脂肪肝的临床研究[J]. 实用肝脏病杂志,2008,11(2):104-105.
|
| [36] |
钱进. 易善复治疗酒精性肝硬化52例临床分析[J]. 右江医学,2007,35(6):642-643.
|
| [37] |
Ilic V, Begic-Janev A. Therapy of HBsAg-positive chronic active hepatitis[J]. Med Welt,1991,42(6):523-525.
|
| [38] |
张孝秩, 贡德曼, 巫善明, 等. 复方多烯磷脂酰胆碱治疗慢性乙型活动性肝炎的随机对照双盲临床试验[J]. 药物流行病学杂志,1995,4(1):4-6.
|
| [39] |
刘丽珍, 蔡水泽. 阿德福韦酯联合多烯磷脂酰胆碱胶囊治疗慢性乙型肝炎肝纤维化[J]. 河南大学学报(医学版),2015,34(3):192-194.
|
| [40] |
Niederau C, Strohmeyer G, Heintges T, et al. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group[J]. Hepatogastroenterology,1998,45(21):797-804.
|
| [41] |
Fassati P, Horejsi J, Fassati M, et al. The effect of essential choline phospholipids on HBsAg and on certain biochemical tests in cirrhosis of the liver[J]. Cas Lek ces,1981,120:56-60.
|
| [42] |
Djuric-Milosavijevic O. Polyunsaturated phosphatidylcholine (EPL) used to prevent hepatic lesions during the treatment of tuberculosis[J]. Epat,1982:28:3-9.
|
| [43] |
Hirose S, Morodoni I, Tanaka M, et al. The prophylactic effects of polyene phosphatidylcholines (EPL) on liver disorders induced by antitubercular drugs (rifampicin, isoniazid)[J]. Kiso to Rinsho,1982,16:4801-4803.
|
| [44] |
贺冬林, 吴孝雄, 罗明. 多烯磷脂酰胆碱治疗原发性肝癌经导管肝动脉化疗栓塞相关性肝损伤的临床研究[J]. 传染病信息,2014,27(2):102-104.
|
| [45] |
王宝利, 崔建东. 多烯磷脂酰胆碱在妇科恶性肿瘤术后辅助化疗时护肝作用研究[J]. 西南国防医药,2012,22(8):859-860.
|
| [46] |
Otegbayo JA, Kuti MA, Ogunbode O, et al. Livolin ameliorates elevations in alanine transaminase in HIV infected patients commencing highly active antiretroviral therapy[J]. Afr J Med Med Sci,2012,41(4):417-422.
|
| [47] |
陈永刚, 朱兴婕. 还原型谷胱甘肽联合多烯磷脂酰胆碱治疗急性药物性肝损伤的临床疗效[J]. 中国药物经济学,2015,10(1):55-56.
|
| [48] |
关荣, 吴治龙. 多烯磷脂酰胆碱联合还原型谷胱甘肽治疗化疗药物性肝损害的疗效观察[J]. 中国肿瘤临床与康复,2014,21(10):1181-1183.
|
| [49] |
张东萍, 肖招英, 巫爱峰, 等. 多烯磷脂酰胆碱联合护肝片治疗药物性肝损伤疗效观察[J]. 中国药师,2014,17(9):1524-1525, 1528.
|
| [50] |
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 临床肝胆病杂志,2015,31(11):1752-1769.
|
| [51] |
赵凤娥, 石振东. 多烯磷脂酰胆碱在自身免疫性肝炎治疗中的作用[J]. 中国实用医刊,2012,39(7):封3.
|
| [52] |
吕雪幼, 叶国良. 多烯磷脂酰胆碱治疗老年中重度脂肪肝的临床研究[J]. 中国临床药理学杂志,2016,32(15):1370-1373.
|
| [53] |
岳欣, 韩国荣, 白淑芬. 多烯磷脂酰胆碱注射液治疗妊娠合并肝功异常的疗效观察[J]. 南京医科大学学报(自然科学版),2009,29(8):1175-1177.
|
| [54] |
胡蓉, 曾义岚, 王丽, 等. 多烯磷脂酰胆碱治疗妊娠早期合并肝炎[J]. 寄生虫病与感染性疾病,2009,7(3):168-169.
|
| [55] |
李永红, 闫芳. 多烯磷脂酰胆碱注射液治疗妊娠期肝内胆汁淤积症的疗效观察[J]. 实用妇产科杂志,2014,30(6):469-471.
|
| [56] |
王迎. 多烯磷脂酰胆碱治疗妊娠期肝内胆汁淤积症的临床研究[J]. 生殖医学杂志,2016,25(2):144-147.
|